Journal of Clinical Endocrinology & Metabolism, Vol 65, 53-58, Copyright © 1987 by Endocrine Society

ARTICLES

Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis

JA Jackson, M Kleerekoper, AM Parfitt, DS Rao, AR Villanueva and B Frame

We present iliac bone histomorphometric data after in vivo double tetracycline labeling and related biochemical data from 14 nonalcoholic men referred for evaluation of symptomatic spinal osteoporosis. Six patients had previously undiagnosed hypogonadism, and 8 had normal gonadal function and no evident etiology for osteoporosis. Bone histomorphometry revealed no differences in structural measurements or resorption indices between the 2 groups. However, compared to reference values for normal postmenopausal women, osteoblast surface, mineralizing surface, and formation rate were normal or modestly increased in the hypogonadal men and significantly reduced in the idiopathic group. There were significant corresponding differences between the 2 groups in the fasting urinary hydroxyproline to creatinine ratio, an index of bone resorption, and serum total alkaline phosphatase, an index of bone formation. Plasma 25-hydroxyvitamin D levels did not differ between the 2 groups and were above 10 ng/mL in all patients. Plasma 1,25-dihydroxyvitamin D [1,25-(OH)2D] levels were normal in the hypogonadal group and significantly reduced in the idiopathic group, but did not correlate with any histological measurements. The formation indices fell substantially in 3 of 4 hypogonadal men after 7-14 months of therapy with testosterone and a calcium supplement. We conclude the following. In vitamin D-replete hypogonadal men with osteoporosis, 1,25-(OH)2D synthesis is normal, and bone remodeling is modestly increased and correctable by hormone replacement therapy, as in normal postmenopausal women. In middle-aged men with idiopathic osteoporosis, there is impairment of 1,25-(OH)2D synthesis and of the recruitment and activity of teams of osteoblasts, as in postmenopausal osteoporosis.

This article has been cited by other articles:

				J. L. Gonzalez-Calvin, F. Gallego-Rojo, R. Fernandez-Perez, F. Casado-Caballero, E. Ruiz-Escolano, and E. G. Olivares Osteoporosis, Mineral Metabolism, and Serum Soluble Tumor Necrosis Factor Receptor p55 in Viral Cirrhosis J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4325 - 4330. [Abstract] [Full Text] [PDF]

				D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson Androgens and Bone Endocr. Rev., June 1, 2004; 25(3): 389 - 425. [Abstract] [Full Text] [PDF]

				M. Benito, B. Gomberg, F. W. Wehrli, R. H. Weening, B. Zemel, A. C. Wright, H. K. Song, A. Cucchiara, and P. J. Snyder Deterioration of Trabecular Architecture in Hypogonadal Men J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1497 - 1502. [Abstract] [Full Text] [PDF]

				J. M. Grossman and C. H. MacLean Quality Indicators for the Management of Osteoporosis in Vulnerable Elders Ann Intern Med, October 16, 2001; 135(8_Part_2): 722 - 730. [Full Text] [PDF]

				C. E. Broeder, J. Quindry, K. Brittingham, L. Panton, J. Thomson, S. Appakondu, K. Breuel, R. Byrd, J. Douglas, C. Earnest, et al. The Andro Project: Physiological and Hormonal Influences of Androstenedione Supplementation in Men 35 to 65 Years Old Participating in a High-Intensity Resistance Training Program Arch Intern Med, November 13, 2000; 160(20): 3093 - 3104. [Abstract] [Full Text] [PDF]

				S F Evans and M W J Davie Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men Ann Rheum Dis, April 1, 2000; 59(4): 269 - 275. [Abstract] [Full Text]

				J. P. Bilezikian Osteoporosis in Men J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3431 - 3434. [Full Text] [PDF]

				H. Sternbach Age-Associated Testosterone Decline in Men: Clinical Issues for Psychiatry Am J Psychiatry, October 1, 1998; 155(10): 1310 - 1318. [Abstract] [Full Text]

				E. S. Kurland, C. J. Rosen, F. Cosman, D. McMahon, F. Chan, E. Shane, R. Lindsay, D. Dempster, and J. P. Bilezikian Insulin-Like Growth Factor-I in Men with Idiopathic Osteoporosis J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2799 - 2805. [Abstract] [Full Text] [PDF]

				R. S. Weinstein, R. L. Jilka, A. M. Parfitt, and S. C. Manolagas The Effects of Androgen Deficiency on Murine Bone Remodeling and Bone Mineral Density Are Mediated via Cells of the Osteoblastic Lineage Endocrinology, September 1, 1997; 138(9): 4013 - 4021. [Abstract] [Full Text] [PDF]

				C.-Y. Guo, T. H. Jones, and R. Eastell Treatment of Isolated Hypogonadotropic Hypogonadism Effect on Bone Mineral Density and Bone Turnover J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 658 - 665. [Abstract] [Full Text] [PDF]